Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-10

Clinical Trial Update: Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating intracameral moxifloxacin as prophylaxis for open-globe endophthalmitis in trauma-related eye injuries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Endophthalmitis, Trauma, Corneal | Phase 4 | Status: UNKNOWN